Evidence map›Paper›PMID 40547050›Full record

ArticleComputational and structural biotechnology journal2025

Granular osteoconductive biopolymer and predictive analysis of its physical property changes in maxillofacial surgery.

Denis G Alekseev, Oleg V Slesarev, Darya V Malchikova, Vyacheslav G Belanov, Natalia A Maksimenko, Vladimir I Platonov, Ravshanbek B Abdullaev

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Denis G AlekseevSamara State Medical University, Samara 443079, Russia.
Oleg V SlesarevSamara State Medical University, Samara 443079, Russia.
Darya V MalchikovaSamara State Medical University, Samara 443079, Russia.
Vyacheslav G BelanovSamara State Medical University, Samara 443079, Russia.
Natalia A MaksimenkoSamara State Medical University, Samara 443079, Russia.
Vladimir I PlatonovSamara National Research University, Samara 443079, Russia.
Ravshanbek B AbdullaevTashkent Medical Academy, Tashkent 100109, Uzbekistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dry bulk fractions of osteoconductive granular biopolymers (OGB) are a common choice for addressing jawbone defects. These, in conjunction with an insulating biological membrane, form bioengineered scaffold structures. In the recipient site, the OGB fraction undergoes biotransformation, morphing from a bulk granular fraction into a stable conglomerate. The biotransformation of the OGB fraction is a physical process initiated by the biological environment of the recipient site. This process is characterized by granule compaction due to reduced intergranular space volume, leading to an uncontrolled decrease in the planned volume of the OGB. This is one of the causes of postoperative complications. This study aims to identify prognostic indicators that characterize the dynamics of changes in the physical property of the total volume of the OGB fraction following the addressing of a jawbone defect (in the postoperative period). To minimize these limitations, the study substantiated the use of prognostic indicators that can characterize the behavior of the entire volume of the OGB fraction within the recipient site during the postoperative period. The study presents the true adsorption capacity (AC

Indexed as

BiopolymersBiotechnologyInnovative materialsMaxillofacial surgeryPhysical propertyTissue engineering

Identifiers

PMID40547050
PMCPMC12182766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.